1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Europe Drug Delivery
Devices Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1.
By Route of Administration (Oral Drug Delivery,
Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery,
Pulmonary Drug Delivery and Others)
5.2.2.
By Device (Syringes, Inhalers, Patch Pumps, And Others)
5.2.3.
By End User (Hospitals & Clinics, Ambulatory Surgery
Centers, Others)
5.2.4.
By Country
5.2.5.
By Company (2022)
5.3.
Market Map
5.3.1. By Route of
Administration
5.3.2. By Device
5.3.3. By End User
5.3.4. By Country
5.4.
Europe: Country Analysis
5.4.1. France Drug Delivery
Devices Market Outlook
5.4.1.1.
Market Size & Forecast
5.4.1.1.1.
By Value
5.4.1.2.
Market Share & Forecast
5.4.1.2.1.
By Route of Administration
5.4.1.2.2.
By Device
5.4.1.2.3.
By End User
5.4.2. Germany Drug
Delivery Devices Market Outlook
5.4.2.1.
Market Size & Forecast
5.4.2.1.1.
By Value
5.4.2.2.
Market Share & Forecast
5.4.2.2.1.
By Route of Administration
5.4.2.2.2.
By Device
5.4.2.2.3.
By End User
5.4.3. United Kingdom Drug
Delivery Devices Market Outlook
5.4.3.1.
Market Size & Forecast
5.4.3.1.1.
By Value
5.4.3.2.
Market Share & Forecast
5.4.3.2.1.
By Route of Administration
5.4.3.2.2.
By Device
5.4.3.2.3.
By End User
5.4.4. Italy Drug Delivery
Devices Market Outlook
5.4.4.1.
Market Size & Forecast
5.4.4.1.1.
By Value
5.4.4.2.
Market Share & Forecast
5.4.4.2.1.
By Route of Administration
5.4.4.2.2.
By Device
5.4.4.2.3.
By End User
5.4.5. Spain Drug Delivery
Devices Market Outlook
5.4.5.1.
Market Size & Forecast
5.4.5.1.1.
By Value
5.4.5.2.
Market Share & Forecast
5.4.5.2.1.
By Route of Administration
5.4.5.2.2.
By Device
5.4.5.2.3.
By End User
5.4.6. Switzerland Drug
Delivery Devices Market Outlook
5.4.6.1.
Market Size & Forecast
5.4.6.1.1.
By Value
5.4.6.2.
Market Share & Forecast
5.4.6.2.1.
By Route of Administration
5.4.6.2.2.
By Device
5.4.6.2.3.
By End User
5.4.7. Netherlands Drug
Delivery Devices Market Outlook
5.4.7.1.
Market Size & Forecast
5.4.7.1.1.
By Value
5.4.7.2.
Market Share & Forecast
5.4.7.2.1.
By Route of Administration
5.4.7.2.2.
By Device
5.4.7.2.3.
By End User
5.4.8. Russia Drug Delivery
Devices Market Outlook
5.4.8.1.
Market Size & Forecast
5.4.8.1.1.
By Value
5.4.8.2.
Market Share & Forecast
5.4.8.2.1.
By Route of Administration
5.4.8.2.2.
By Device
5.4.8.2.3.
By End User
5.4.9. Sweden Drug Delivery
Devices Market Outlook
5.4.9.1.
Market Size & Forecast
5.4.9.1.1.
By Value
5.4.9.2.
Market Share & Forecast
5.4.9.2.1.
By Route of Administration
5.4.9.2.2.
By Device
5.4.9.2.3.
By End User
5.4.10. Belgium Drug
Delivery Devices Market Outlook
5.4.10.1. Market Size & Forecast
5.4.10.1.1.
By Value
5.4.10.2. Market Share & Forecast
5.4.10.2.1.
By Route of Administration
5.4.10.2.2.
By Device
5.4.10.2.3.
By End User
6.
Market Dynamics
6.1.
Drivers
6.2.
Challenges
7.
Market Trends & Developments
8.
Competitive Landscape
8.1. F. Hoffmann-La Roche Ltd
8.2. Antares Pharma
8.3. Novartis AG
8.4. 3M Company
8.5. Sulzer Ltd
8.6. Gerresheimer AG
8.7. Sanofi S.A.
8.8. Johnson & Johnson Services, Inc.
8.9. Bayer AG
8.10.
GlaxoSmithKline plc
9. Strategic Recommendations